Research shows both men and women benefit
The four-week mark without weight loss is too early to judge effectiveness for most people
Keywords: pediatric obesity, GLP-1 receptor agonists, semaglutide, adolescent weight management, pharmacotherapy, long-term safety, health equity, obesity treatment Introduction The global pediatric obesity epidemic represents one of the most pressing public health challenges of the 21st century
Tirzepatide Dosage Chart Tirzepatide follows a structured dose escalation to minimize side effects: Weeks 1-4: 2.5mg weekly (starting dose) Weeks 5-8: 5mg weekly Weeks 9-12: 7.5mg weekly Weeks 13-16: 10mg weekly Week 17+: 12.5mg or 15mg weekly (if needed) Dose increases happen every 4 weeks, and Keely monitors your progress and side effects at each step to ensure a safe, effective experience
This helps to preserve the medications potency and ensures it remains effective when youre ready to use it